コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 designed, synthesized, and evaluated against Trypanosoma brucei brucei .
2 rized that protects humans from infection by Trypanosoma brucei brucei.
3 oodstream and procyclic life cycle stages of Trypanosoma brucei brucei.
4 he purine-specific nucleoside hydrolase from Trypanosoma brucei brucei.
5 LF2) that are lytic for the African parasite Trypanosoma brucei brucei.
6 de hydrolase (IAG-nucleoside hydrolase) from Trypanosoma brucei brucei.
7 ts: I172V, I172A, L232A, and P168A (TIM from Trypanosoma brucei brucei); a 208-TGAG for 208-YGGS loop
8 postmitochondrial supernatants prepared from Trypanosoma brucei brucei and Crithidia fasciculata, we
9 (HDL) found in human serum that is toxic to Trypanosoma brucei brucei and may be critical in prevent
10 e mitochondrial DNA (kinetoplast or kDNA) of Trypanosoma brucei brucei and related kinetoplastid prot
12 nd to be a potent inhibitor against cultured Trypanosoma brucei brucei and Trypanosoma brucei rhodesi
13 were evaluated against bloodstream forms of Trypanosoma brucei brucei and Trypanosoma brucei rhodesi
14 against the parasites Plasmodium falciparum, Trypanosoma brucei brucei, and Trypanosoma cruzi will be
15 lipid-free Hpr and apoL-I were both toxic to Trypanosoma brucei brucei but with specific activities a
16 everal African trypanosome species including Trypanosoma brucei brucei, but not the human-infective p
17 al immunity of humans to the cattle pathogen Trypanosoma brucei brucei, but not to the morphologicall
18 GAP for wildtype TIM from muscle sources and Trypanosoma brucei brucei, but partitioning of the enedi
20 h a single-digit micromolar activity against Trypanosoma brucei brucei (EC50 = 2.97 muM), thus being
21 ine transport activities in bloodstream form Trypanosoma brucei brucei found that these cells express
22 resistance of humans to the cattle pathogen Trypanosoma brucei brucei has been attributed to the pre
23 al immunity of humans to the cattle pathogen Trypanosoma brucei brucei has been attributed to the pre
25 een of approximately 87000 compounds against Trypanosoma brucei brucei identified a number of promisi
27 responses in the penetration of T cells and Trypanosoma brucei brucei into the brain was studied in
28 ate immunity against the veterinary pathogen Trypanosoma brucei brucei is conferred by trypanosome ly
29 serum that protects from infection by lysing Trypanosoma brucei brucei, is also bound and endocytosed
30 against most African trypanosomes, including Trypanosoma brucei brucei, is mediated by a minor subcla
31 st four strains of African trypanosomes, one Trypanosoma brucei brucei isolate, and several clinical
32 desiense LouTat 1 with the 117 VSG gene from Trypanosoma brucei brucei MiTat 1.4 in order to produce
34 d low micromolar levels of inhibition of the Trypanosoma brucei brucei parasite grown in culture.
35 tion in triosephosphate isomerase (TIM) from Trypanosoma brucei brucei results in a small 6-fold decr
36 d by wildtype triosephosphate isomerase from Trypanosoma brucei brucei (Tbb TIM) and a monomeric vari
37 HAP) by triosephosphate isomerase (TIM) from Trypanosoma brucei brucei (Tbb) has been investigated.
38 Glu-167 of triosephosphate isomerase from Trypanosoma brucei brucei (TbbTIM) acts as the base to d
39 certain mammalian trypanosomes, most notably Trypanosoma brucei brucei, the causative agent of a wast
41 xperimental-model species of Kinetoplastida -Trypanosoma brucei brucei, Trypanosoma cruzi and Leishma
42 or activity against the pathogenic parasites Trypanosoma brucei brucei, Trypanosoma cruzi, and Leishm
43 31-fold more active against bloodstream-form Trypanosoma brucei brucei trypomastigotes engineered to
44 cyclic and long slender bloodstream forms of Trypanosoma brucei brucei was investigated by means of s
45 een of approximately 87000 compounds against Trypanosoma brucei brucei, we recently identified eight
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。